Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sarepta Therapeutics Inc SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy... see more

Bullboard (NDAQ:SRPT)

View:
Post by MikeTesteron Aug 03, 2024 6:24am

Sarepta Therapeutics (NASDAQ:SRPT): Analysis of Financial Pe

https://beyondspx.com/2024/08/02/sarepta-therapeutics-nasdaqsrpt-analysis-of-financial-performance-and-pipeline-progress/
Post by whytestockson Jun 21, 2024 10:45am

Buy Recommendation Issued On SRPT By Needham

JUST IN: $SRPT Buy Recommendation Issued On SRPT By Needham2024-06-21 10:15:03 ET Needham analyst issues BUY recommendation for SRPT on June 21, 2024 08:32AM ET. The previous analyst recommendation ...more  
Post by whytestockson Jun 21, 2024 10:30am

FDA Approves Expanded Use For Sarepta's Rare Muscular Dystro

NEWS: $SRPT FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy | BenzingaThursday, the FDA approved labeled indication for Sarepta Therapeutics Inc@s (NASDAQ:SRPT ...more  
Post by whytestockson Feb 16, 2024 3:00pm

Why Sarepta Therapeutics Stock Is Soaring Today

News; $SRPT Why Sarepta Therapeutics Stock Is Soaring Today2024-02-16 11:23:56 ET Shares of Sarepta Therapeutics (NASDAQ: SRPT) were soaring 10.4% higher as of 10:58 a.m. ET on Friday. The big gain ...more  
Comment by tamaracktopon Jan 07, 2021 5:58pm

RE:Don't sweat today's trading people

Sincere appologies. Wrong board.
Post by tamaracktopon Jan 07, 2021 5:50pm

Don't sweat today's trading people

In marketland, today is already yesterday. Yesterday is history Tomorrow's a mystery Today is a gift from God That's why they call it The Present After today, Xebec is a present. A " ...more  
Post by Mil_Man54on Dec 01, 2020 10:09am

Bonvoyage12....Pathetic Pumper

This pumper spams multiple boards with paid PR BS......depserately trying to promote losing stocks....ignore him and report him.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities